LJM1R — Latvijas Juras Medicinas Centrs AS Share Price
Last trade - 00:00- €6.40m
- €5.73m
- €9.84m
- 27
- 64
- 14
- 25
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.95 | ||
| Price to Tang. Book | 0.95 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.65 | ||
| EV to EBITDA | 10.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.2% | ||
| Return on Equity | -0.21% | ||
| Operating Margin | -0.14% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 7.27 | 7.08 | 9.36 | 9.7 | 9.84 | n/a | n/a | 8.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +71.44 | +229.81 | -28 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Latvijas Juras Medicinas Centrs AS (Latvian Maritime Medicine Center JSC or LJMC JSC) is a Latvia-based company engaged in the provision of healthcare services. LJMC operates Central Hospital, Vecmilgravis Hospital and Northern Diagnostic Center, as well as Vecmilgravis Primary Health Care Center (Vecmilgravis PHCC) and Sarkandaugava ambulatory health care center. It provides diagnostics services, such as cardiovascular, surgical, radiological, gastrointestinal disease diagnostics and magnetic resonance. The Company operates two subsidiaries, Juras medicina Ltd and Neirozu klinika SIA. It is active domestically and offers its services on the whole territory of Latvia. In addition, it cooperates with health insurance companies.
Directors
- Martins Birks CSU
- Janis Birks CMG (62)
- Gunta Kaufmane CAO
- Anatolijs Ahmetovs MGB
- Juris Imaks MGB
- Ineta Gadzjus SUB
- Jevgenijs Kalejs SUB
- Uldis Osis SUB (70)
- Viesturs Silins SUB
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 27th, 1996
- Public Since
- May 11th, 1998
- No. of Employees
- 361
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- OMX Baltic Exchange - Riga
- Shares in Issue
- 800,000
- Address
- Patversmes iela 27, RIGA, 1005
- Web
- https://www.ljmc.lv/
- Phone
- +371 67889000
- Auditors
- KPMG Baltics SIA
Upcoming Events for LJM1R
FAQ
As of Today at 19:13 UTC, shares in Latvijas Juras Medicinas Centrs AS are trading at €8.00. This share price information is delayed by 15 minutes.
Shares in Latvijas Juras Medicinas Centrs AS last closed at €8.00 and the price had moved by -25.23% over the past 365 days. In terms of relative price strength the Latvijas Juras Medicinas Centrs AS share price has underperformed the FTSE Global All Cap Index by -31.51% over the past year.
There is no consensus recommendation for this security.
Latvijas Juras Medicinas Centrs AS does not currently pay a dividend.
Latvijas Juras Medicinas Centrs AS does not currently pay a dividend.
Latvijas Juras Medicinas Centrs AS does not currently pay a dividend.
To buy shares in Latvijas Juras Medicinas Centrs AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €8.00, shares in Latvijas Juras Medicinas Centrs AS had a market capitalisation of €6.40m.
Here are the trading details for Latvijas Juras Medicinas Centrs AS:
- Country of listing: Latvia
- Exchange: RIX
- Ticker Symbol: LJM1R
Based on an overall assessment of its quality, value and momentum Latvijas Juras Medicinas Centrs AS is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Latvijas Juras Medicinas Centrs AS. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -28.82%.
As of the last closing price of €8.00, shares in Latvijas Juras Medicinas Centrs AS were trading -26.52% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Latvijas Juras Medicinas Centrs AS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €8.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Latvijas Juras Medicinas Centrs AS' management team is headed by:
- Martins Birks - CSU
- Janis Birks - CMG
- Gunta Kaufmane - CAO
- Anatolijs Ahmetovs - MGB
- Juris Imaks - MGB
- Ineta Gadzjus - SUB
- Jevgenijs Kalejs - SUB
- Uldis Osis - SUB
- Viesturs Silins - SUB